| Literature DB >> 25124335 |
Qing Liu1, Zheng-Qin Yin2, Ning Ke1, Lin Chen1, Xin-Ke Chen1, Jing Fang1, Xiu-Rong Chen1, Jun Xiao1, Kang Hu1, Xuan Zhang1, Yan Xiong1, Hui Shi1, Jie Li1, Hong-Jian Long1, Kang-Lin Zhang1, Zhi-Yu Chen1, Lian-Hong Pi1.
Abstract
BACKGROUND: The aim of this study was to screen for retinopathy of prematurity (ROP) in southwestern China and understand the prevalence and risk factors of ROP, which may provide evidence useful in the prevention and treatment of ROP. MATERIAL/Entities:
Mesh:
Year: 2014 PMID: 25124335 PMCID: PMC4144944 DOI: 10.12659/MSM.890688
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Demographic data of the studied cases (n=1614).
| Data | n (%) | Gestational age (w) | Birth weight (g) | |
|---|---|---|---|---|
| Total | 1614 (100.0%) | 32.34±2.19 | 1773.7±389.9 | |
| Gender | M | 898 (55.6%) | 32.33±2.16 | 1804.3±382.4 |
| F | 716 (44.4%) | 32.35±2.23 | 1735.4±396.0 | |
| Source | Non-hospitalized | 1155 (71.6%) | 32.63±2.14 | 1842.0±382.7 |
| Hospitalized | 459 (28.4%) | 31.60±2.13*** | 1601.8±353.5 |
n – number;
P<0.001 vs. non-hospitalized patients.
Figure 1A) Prevalence of retinopathy of prematurity (ROP) in different years of different populations; (B) Prevalence of ROP of different populations in different years. All the subjects were divided into total population (n=1614), non-hospitalized patients (n=1155) and hospitalized patients (n=459). In addition, 245, 356, 467, and 546 subjects received diagnosis at 2009, 2010, 2011, and 2012, respectively. A value of P<0.0125 was considered statistically significant when comparisons were done between 2 groups (chi-squared test: P=0.05/[n(n−1)/2+1]; n=number of groups=3).
Figure 2Prevalence of retinopathy of prematurity (ROP) in subjects of different gestational ages. The prevalence of ROP was 41.2%, 27.5%, 12.7%, 6.4%, and 2.6% in subjects with gestational age of ≤28 w, 28–30 w, 30–32 w, 32–34w, and 34–36 w, respectively.
Prevalence of ROP in subjects of different gestational ages.
| Gestational age (w) | No. of subjects | No. of ROP patients | Prevalence of ROP(%) |
|---|---|---|---|
| ≤28 w | 85 | 35 | 41.2 |
| 28–30 w | 258 | 71 | 27.5 |
| 30–32 w | 464 | 59 | 12.7 |
| 32–34 w | 532 | 34 | 6.4 |
| 34–36 w | 275 | 7 | 2.6 |
No. – number; ROP – retinopathy of prematurity.
Prevalence of ROP in subjects of different gestational ages.
| Gestational age (w) | χ2 | P |
|---|---|---|
| ≤28w/28–30w | 5.585 | <0.0045 |
| ≤28w/30–32w | 41.008 | <0.0045 |
| ≤28w/32–34w | 89.286 | <0.0045 |
| ≤28w/34–36w | 94.026 | <0.0045 |
| 28–30w/30–32w | 24.613 | <0.0045 |
| 28–30w/32–34w | 67.300 | <0.0045 |
| 28–30w/34–36w | 66.458 | <0.0045 |
| 30–32w/32–34w | 11.711 | <0.0045 |
| 30–32w/34–36w | 21.958 | <0.0045 |
| 32–34w/34–36w | 5.559 | <0.0045 |
(P=0.05/[n(n−1)/2+1]; n – number of groups=5; P=0.0045.
Figure 3Prevalence of retinopathy of prematurity (ROP) in preterm infants with different birth weights. The prevalence of ROP was 64.0%, 24.0%, 10.0%, and 3.0% in preterm subjects with birth weight of ≤1000 g, 1000–1500 g, 1500–2000 g, and 2000–2500 g, respectively.
Prevalence of ROP in preterm infants with different birth weights.
| Birth weight (g) | No. of subjects | No. of ROP patients | Prevalence of ROP (%) |
|---|---|---|---|
| ≤1000 | 24 | 15 | 64.0 |
| 1000–1500 | 438 | 103 | 24.0 |
| 1500–2000 | 692 | 72 | 10.0 |
| 2000–2500 | 460 | 16 | 3.0 |
No. – number; ROP – retinopathy of prematurity.
Prevalence of ROP among subjects with different birth weights.
| Birth weight (g) | χ2 | P |
|---|---|---|
| ≤1000/1000–1500 | 18.183 | <0.0071 |
| ≤1000/1500–2000 | 54.194 | <0.0071 |
| ≤1000/2000–2500 | 122.887 | <0.0071 |
| 1000~1500/1500–2000 | 35.230 | <0.0071 |
| 1000~1500/2000–2500 | 78.365 | <0.0071 |
| 1500~2000/2000–2500 | 18.789 | <0.0071 |
(P=0.05/[n(n−1)/2+1]; n – number of groups=4; P=0.0071); ROP – retinopathy of prematurity.
Univariate analysis of risk factors of ROP.
| Risk factors | ROP patients | Non-ROP subjects | t | P | |
|---|---|---|---|---|---|
| Neonatal factors | Gestational age (w) | 30.3±2.2 | 32.0±2.0 | t=6.97 | <0.001 |
| Birth weight (g) | 1415±305 | 1660±350 | t=6.18 | <0.001 | |
| Total days of oxygen supplement (d) | 27.2±21.8 | 14.3±12.2 | t=–5.46 | <0.001 | |
| Days of mechanical ventilation (d) | 3.6±8.8 | 1.4±3.5 | t=–3.75 | <0.001 | |
| Days of non-mechanical ventilation (d) | 23.6±18. 4 | 12.9±11.3 | t=–5.35 | <0.001 | |
| Sex (M/F) | 50/42 | 212/155 | χ2=0.351 | 0.554 | |
| Neonatal pneumonia | 87 | 346 | χ2=0.011 | 0.915 | |
| ARDS, apnea, respiratory failure, asphyxia | 55 | 160 | χ2=7.739 | 0.005 | |
| Pulmonary hemorrhage | 6 | 21 | χ2=0.085 | 0.771 | |
| Encephalopathy of preterm infants | 78 | 255 | χ2=8.647 | 0.003 | |
| Sepsis | 11 | 34 | χ2=0.603 | 0.437 | |
| Congenital heart diseases | 47 | 163 | χ2=1.320 | 0.251 | |
| Myocardial injury | 55 | 254 | χ2=2.972 | 0.085 | |
| Coagulation dysfunction | 45 | 179 | χ2=0.001 | 0.981 | |
| Hyperbilirubinemia, pathological jaundice | 49 | 203 | χ2=0.125 | 0.724 | |
| Hypoproteinemia | 36 | 98 | χ2=5.496 | 0.019 | |
| Hypoglycemia | 9 | 39 | χ2=0.056 | 0.813 | |
| Hyperglycemia | 16 | 37 | χ2=3.848 | 0.050 | |
| Anemia | 78 | 255 | χ2=8.647 | 0.003 | |
| Acid-base imbalance | 47 | 167 | χ2=0.921 | 0.337 | |
| Oxygen supplement | 90 | 331 | χ2=5.648 | 0.017 | |
| Mechanical ventilation | 29 | 90 | χ2=1.876 | 0.171 | |
| Blood transfusion | 77 | 206 | χ2=23.642 | <0.001 | |
| Multiple deliveries | 28 | 123 | χ2=2.399 | 0.494 | |
| Vasoactive substances | 57 | 152 | χ2=12.513 | <0.001 | |
| Pulmonary surfactant | 22 | 49 | χ2=6.275 | 0.012 | |
| Erythropoietin | 15 | 49 | χ2=0.535 | 0.465 | |
| Maternal factors | Maternal age | 29.45±5.79 | 29.11±5.45 | t=–0.516 | 0.606 |
| Eutocia/Cesarean section | 43/49 | 158/209 | χ2=0.406 | 0.524 | |
| premature rupture of fetal membranes | 36 | 156 | χ2=0.001 | 0.977 | |
| Amniotic fluid abnormalities | 5 | 27 | χ2=0.419 | 0.517 | |
| Fetal distress | 10 | 45 | χ2=0.135 | 0.713 | |
| Placenta praevia | 3 | 32 | χ2=3.112 | 0.078 | |
| Placental abruption | 3 | 10 | χ2<0.001 | 1.000 | |
| Gestational hypertension | 7 | 34 | χ2=0.248 | 0.619 | |
| Gestational cholestasis | 5 | 87 | χ2=0.002 | 0.961 | |
| Gestational diabetes | 2 | 20 | χ2=1.086 | 0.297 | |
| Anemia in pregnancy | 5 | 24 | χ2=0.152 | 0.697 | |
| Cold | 25 | 110 | χ2=0.278 | 0.598 | |
| Dexamethasone | 20 | 101 | χ2=1.267 | 0.26 | |
| Penicillin | 1 | 14 | χ2=0.976 | 0.323 | |
| Tocolytic agents | 5 | 11 | χ2=0.676 | 0.411 |
Total days of oxygen supplementation = days of mechanical ventilation + days of non-mechanical ventilation;
Days of non-mechanical ventilation = total days of oxygen supplementation via nasal tube, mask or chamber.
ROP – retinopathy of prematurity; ARDS – Acute Respiratory Distress Syndrome; HIE – hypoxic-ischemic encephalopathy.
Logistic regression analysis of risk factors of ROP.
| Risk factor | OR | 95% CI | P |
|---|---|---|---|
| Gestational age | 0.82 | 0.707–0.950 | 0.008 |
| Birth weight | 0.999 | 0.998–1.000 | 0.049 |
| Total days of oxygen supplement | 1.02 | 1.005–1.035 | 0.008 |
| Myocardial injury | 2.327 | 1.383–3.917 | 0.001 |
ROP – retinopathy of prematurity; OR – odds ratio.